Novo Holdings, Nordic Capital and Astorg to invest in ERT

The private equity group Astorg invests in eResearch Technology Inc. ("ERT") and will enter as a partner alongside existing owners Novo Holdings A/S, Nordic Capital, and the ERT management team.  Plesner has advised Novo Holdings A/S in relation to the transaction.

ERT is a leading provider of electronic data collection solutions for clinical drug development programmes. The private equity group Astorg will join Novo Holdings A/S and Nordic Capital as a new co-investor, and together with the ERT management team the new ownership group will invest in continued development of the business and ERT's future growth.

Following Novo Holdings A/S' and Nordic Capital's investment in 2016 ERT has grown significantly, having doubled revenue. ERT is headquartered in the US and has supported more than 50% of all FDA drug approvals over the last five years.

Completion of the investment is subject to customary regulatory approvals.

Latest news on M&A

Mergers and Acquisitions